NeuroAudit

Neuromodulation Protocols for Personalized Brain Disease Treatment

Health Tech & Life Sciences
Active
Seed Gan Sorek, Israel Founded 2016
Last updated 2026-06-18
Total raised
$200K
Last:
Stage
Seed
Founded
2016
Headcount
3
HQ
Gan Sorek, Israel
Sector
Health Tech & Life Sciences

About

NeuroAudit, the developer of neuro stimulus neurotechnology, is currently working on a cognitive boost patch for the treatment of brain disorders such as Alzheimers disease and cognitive disorders. Based on blood conduction directly to the brain using a unique algorithm, the device transmits a noninvasive, pure signal through a patch attached to the skin. The device is not mounted in or near the ears of the patient. NeuroAudit is focused on addressing the complexities of neurological disorders by continuously monitoring the state of the brain while analyzing the measured data and controlling brain stimulation in real time in order to better understand the impact on the brain. The companys noninvasive stimulation has showed improvements in certain cognitive operations and was able to send a pure tone to a completely deaf individual via the blood using an ultrasonic algorithm. Additional use cases include creating a new brain-hearing sense to expand the range of the human brains hearing up to 100 KHz and using specific modulations to expand a individuals level of cognition.

Funding history · 1 round · $200K total

Date unknown
$200K

Q&A

What is NeuroAudit's primary focus?
NeuroAudit is developing neuro stimulus neurotechnology, specifically a cognitive boost patch for treating brain disorders like Alzheimer's disease and cognitive disorders.
How does NeuroAudit's technology work?
NeuroAudit's device uses blood conduction directly to the brain via a noninvasive patch, transmitting a pure signal using a unique algorithm. It continuously monitors the brain, analyzes data, and controls stimulation in real time.
What are some demonstrated capabilities of NeuroAudit's noninvasive stimulation?
NeuroAudit's noninvasive stimulation has shown improvements in certain cognitive operations and was able to send a pure tone to a completely deaf individual via the blood using an ultrasonic algorithm.
What additional use cases does NeuroAudit envision for its technology?
NeuroAudit envisions creating a new brain-hearing sense to expand human hearing up to 100 KHz and using specific modulations to expand an individual's level of cognition.
When was NeuroAudit founded?
NeuroAudit was founded in February 2016.
What is NeuroAudit's current employee count?
NeuroAudit has 1-10 employees.
What is the total amount of funding NeuroAudit has raised?
NeuroAudit has raised a total of $200,000.
Who is the CEO of NeuroAudit?
Dan Anzyo is the CEO and a founder of NeuroAudit.

Team · 1

Founder · CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

Verified

Tags

non-invasivemedical-devicesadhdultrasoundpersonalizationalzheimers-diseaseartificial-intelligencetreatmentsautismmental-healthneuroscience
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)